Health CarePharmaceuticals & Biotechnology
  • Price (ILa)8,421.00
  • Today's Change-88.00 / -1.03%
  • Shares traded391.93k
  • 1 Year change-26.07%
  • Beta1.4988
Data delayed at least 20 minutes, as of Jul 16 2018 15:24 BST.
More ▼

Profile data is unavailable for this security.

About the company

Teva Pharmaceutical Industries Limited is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. The Company develops, manufactures and sells generic medicines in a range of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams. Its specialty medicines business focuses on delivering a range of solutions to patients and providers through medicines, devices and services in various regions and markets around the world. Its specialty medicines business includes its core therapeutic areas of central nervous system (CNS) and respiratory medicines with a focus on asthma and chronic obstructive pulmonary disease. It also has specialty products in oncology, women's health and selected other areas.

  • Revenue in ILS (TTM)79.35bn
  • Net income in ILS-62.22bn
  • Incorporated1944
  • Employees51.80k
  • Location
    Teva Pharmaceutical Industries Ltd5 Basel St.,P.O. Box 3190PETAH TIKVA 49131IsraelISR
  • Phone+972 39267267
  • Fax+972 39234050
  • Websitehttp://www.tevapharm.com
More ▼

Institutional shareholders

4.55%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 May 201819.42m1.91%
Norges Bank Investment Managementas of 31 Dec 201712.96m1.28%
Canada Pension Plan Investment Boardas of 31 Mar 20183.30m0.32%
Formuepleje A/S Fondsm�glerselskabas of 31 Dec 20162.51m0.25%
APG Asset Management NVas of 30 Jun 20172.03m0.20%
State of Wisconsin Investment Boardas of 31 Dec 20161.95m0.19%
Charles Schwab Investment Management, Inc.as of 06 Jun 20181.48m0.15%
BlackRock Advisors (UK) Ltd.as of 06 Jun 20181.18m0.12%
Migdal Mutual Funds Ltd.as of 29 Mar 2018756.56k0.07%
The Caisse de d�p�t et placement du Qu�becas of 31 Dec 2017720.03k0.07%
More ▼
Data from 31 Dec 2017 - 31 Mar 2018Source: FactSet Research Systems Inc.
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.